A partnership between Oxford University’s Oncology Clinical Trials Office (OCTO) and the Primary Care Clinical Trials Unit (PC-CTU) has received £1 million over the next five years from Cancer Research UK, supporting efforts to deliver a portfolio of precision prevention and early detection cancer trials. Click to read more.